Baxter reports Q3 GAAP loss of $5.83/share on $3.1B Hillrom impairment; adjusted EPS $0.82

BAXTER INTERNATIONAL INC

2022-Q3 EPS reported -$5.20 revenue$11,226,000,000

Revenue $3.8B, up 17% reported, 23% constant currency, slightly positive operationally.
GAAP net loss $2.9B ($5.83/share) driven by $3.1B pre-tax impairment of Hillrom goodwill and intangibles.
Adjusted EPS $0.82, down 20% YoY; full-year adjusted EPS guidance set at $3.53 to $3.60.
U.S. sales $1.8B (+40% reported, -1% operational); International $1.9B (+1% reported, +2% operational).
FDA classified Ahmedabad manufacturing site as VAI (compliant), enabling new drug product approvals.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

BAXTER INTERNATIONAL INC reported third quarter of 2022 results: revenue $3.8 billion, net income ($2.9 billion), EPS ($5.83).

Period: third quarter of 2022
Revenue: $3.8 billion
Net income: ($2.9 billion)
EPS: ($5.83)
Result: reported results

Exact text from the filing

attachments, is furnished as Exhibit 99.1 to this report. --- EX-99.1 (EX-99.1) --- FOR IMMEDIATE RELEASE BAXTER REPORTS THIRD-QUARTER 2022 RESULTS • Third-quarter revenue of $3.8 billion increased 17% on a reported basis, 23% on a constant currency basis and rose slightly on an operational basis 1 • Third-quarter U.S. GAAP earnings (loss) per share (EPS) were

View on SEC.gov

Browse all earnings releases →

BAXTER INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0001628280-22-027148

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.